Ji-yong Liu-Jiyong
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pharmacovigilance insights into drug-induced hypercalcemia: evidence from the U.S. FDA Adverse Event Reporting System (FAERS) database.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: November 26, 2025
Fecal metagenome and plasma metabolome analyses reveal changes in gut microbiota composition and plasma metabolites in rats with abemaciclib-induced diarrhea.
Journal: BMC gastroenterology
Published: June 17, 2025
Current status and trends of anti-tumor biosimilars in China from 2019 to 2023: A cross-sectional analysis.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: May 23, 2025
A superior method for antitumor therapy and application: dual-ligand nanomedicines.
Journal: Journal of materials chemistry. B
Published: May 21, 2025
Different interventions to prevent preterm birth in pregnant women with cervical shortening during pregnancy: a protocol for a network meta-analysis.
Journal: BMJ open
Published: November 12, 2024
Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.
Journal: Journal of nanobiotechnology
Published: July 04, 2024
Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy.
Journal: Acta pharmacologica Sinica
Published: May 16, 2024
αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma.
Journal: Journal of nanobiotechnology
Published: May 26, 2022
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment.
Journal: Biomaterials
Published: December 13, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026